Vir Biotechnology (VIR) Total Current Liabilities (2018 - 2025)
Vir Biotechnology's Total Current Liabilities history spans 8 years, with the latest figure at $92.8 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 22.44% to $92.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $92.8 million, a 22.44% decrease, with the full-year FY2025 number at $92.8 million, down 22.44% from a year prior.
- Total Current Liabilities hit $92.8 million in Q4 2025 for Vir Biotechnology, up from $75.2 million in the prior quarter.
- Over the last five years, Total Current Liabilities for VIR hit a ceiling of $702.4 million in Q1 2022 and a floor of $75.2 million in Q3 2025.
- Historically, Total Current Liabilities has averaged $248.5 million across 5 years, with a median of $170.2 million in 2023.
- Biggest five-year swings in Total Current Liabilities: soared 540.29% in 2021 and later crashed 80.62% in 2024.
- Tracing VIR's Total Current Liabilities over 5 years: stood at $341.2 million in 2021, then soared by 49.76% to $511.0 million in 2022, then plummeted by 65.68% to $175.4 million in 2023, then plummeted by 31.78% to $119.7 million in 2024, then fell by 22.44% to $92.8 million in 2025.
- Business Quant data shows Total Current Liabilities for VIR at $92.8 million in Q4 2025, $75.2 million in Q3 2025, and $105.0 million in Q2 2025.